Triweekly XELOX Versus Single Capecitabine Concomitant with Neoadjuvant Radiotherapy for Locally Advanced Rectal Cancer

被引:0
|
作者
Li, A. [1 ,2 ]
Xu, B. [1 ,3 ]
机构
[1] Fujian Med Univ, Affiliated Union Hosp, Dept Radiat Oncol, Fuzhou, Peoples R China
[2] Fujian Med Univ, Dept Radiat Oncol, Coll Clin Med, Fuzhou, Peoples R China
[3] Fujian Med Univ, Dept Med Imagine Technol, Coll Med Technol & Engn, Fuzhou, Peoples R China
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3524
引用
收藏
页码:E658 / E658
页数:1
相关论文
共 50 条
  • [1] Neoadjuvant capecitabine and oxaliplatin (XELOX) with bevacizumab for locally advanced rectal cancer
    Hasegawa, Junichi
    Mizushima, Tsunekazu
    Kim, Ho Min
    Miyake, Yasuhiro
    Takemoto, Hiroyoshi
    Tamagawa, Hiroshi
    Noura, Shingo
    Ohue, Masayuki
    Fujii, Makoto
    Fujie, Yuichiro
    Ota, Hirofumi
    Kato, Takeshi
    Fukunaga, Mutsumi
    Takemasa, Ichiro
    Ikeda, Masataka
    Yamamoto, Hirofumi
    Sekimoto, Mistugu
    Nezu, Riichiro
    Doki, Yuichiro
    Mori, Masaki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [2] Long-Term Outcome of Oxaliplatin and Capecitabine (XELOX) Concomitant with Neoadjuvant Radiotherapy and Extended to the Resting Period in High Risk Locally Advanced Rectal Cancer
    Tang, Jinghua
    Wu, Xiaojun
    Bai, Yanfang
    Gao, Yuanhong
    Jiang, Wu
    Kong, Lingheng
    Lin, Junzhong
    Wan, Desen
    Pan, Zhizhong
    Ding, Peirong
    [J]. JOURNAL OF CANCER, 2018, 9 (08): : 1365 - 1370
  • [3] A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer
    Giampietro Gasparini
    Francesco Torino
    Takayuki Ueno
    Stefano Cascinu
    Teresa Troiani
    Alberto Ballestrero
    Rossana Berardi
    Junichi Shishido
    Akihiko Yoshizawa
    Yukiko Mori
    Satoshi Nagayama
    Paola Morosini
    Masakazu Toi
    [J]. Angiogenesis, 2012, 15 : 141 - 150
  • [4] Oxaliplatin and capecitabine concomitant with neoadjuvant radiotherapy and extended to the resting period in high risk locally advanced rectal cancer
    Gao, Y. -H.
    Zhang, X.
    An, X.
    Cai, M. -Y.
    Zeng, Z. -F.
    Chen, G.
    Kong, L. -H.
    Lin, J. -Z.
    Wan, D. -S.
    Pan, Z. -Z.
    Ding, P. -D.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2014, 190 (02) : 158 - 164
  • [5] A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer
    Gasparini, Giampietro
    Torino, Francesco
    Ueno, Takayuki
    Cascinu, Stefano
    Troiani, Teresa
    Ballestrero, Alberto
    Berardi, Rossana
    Shishido, Junichi
    Yoshizawa, Akihiko
    Mori, Yukiko
    Nagayama, Satoshi
    Morosini, Paola
    Toi, Masakazu
    [J]. ANGIOGENESIS, 2012, 15 (01) : 141 - 150
  • [6] CAPECITABINE INITIALLY CONCOMITANT TO RADIOTHERAPY THEN PERIOPERATIVELY ADMINISTERED IN LOCALLY ADVANCED RECTAL CANCER
    Zampino, Maria Giulia
    Magni, Elena
    Leonardi, Maria Cristina
    Petazzi, Elena
    Santoro, Luigi
    Luca, Fabrizio
    Chiappa, Antonio
    Petralia, Giuseppe
    Trovato, Cristina
    Fazio, Nicola
    Orecchia, Roberto
    Nole, Franco
    de Braud, Filippo
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (02): : 421 - 427
  • [7] A Feasibility Study of Neoadjuvant XELOX Without Radiotherapy for Locally Advanced Lower Rectal Cancer
    Ueki, Takashi
    Manabe, Tatsuya
    Inoue, Shigetaka
    Ienaga, Jun
    Yamanaka, Naoki
    Egami, Takuya
    Ishikawa, Mikimasa
    Konomi, Hiroyuki
    Ikubo, Akashi
    Nagayoshi, Kinuko
    Nakamura, Masafumi
    Tanaka, Masao
    [J]. ANTICANCER RESEARCH, 2016, 36 (02) : 741 - 747
  • [8] Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer
    Dunst, Juergen
    Debus, Juergen
    Rudat, Volker
    Wulf, Joern
    Budach, Wilfried
    Hoelscher, Tobias
    Reese, Thomas
    Mose, Stephan
    Roedel, Claus
    Zuehlke, Helmut
    Hinke, Axel
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2008, 184 (09) : 450 - 456
  • [9] Comparison of Capecitabine (Xeloda) vs. Combination of Capecitabine and Oxaliplatin (XELOX) as Neoadjuvant CRT for Locally Advanced Rectal Cancer
    Joybari, Ali Yaghobi
    Azadeh, Payam
    Babaei, Siamak
    Kamal, Farnaz Hosseini
    [J]. PATHOLOGY & ONCOLOGY RESEARCH, 2019, 25 (04) : 1599 - 1605
  • [10] Comparison of neoadjuvant oral chemotherapy with UFT plus Folinic acid or Capecitabine concomitant with radiotherapy on locally advanced rectal cancer
    Conde, Sofia
    Borrego, Margarida
    Teixeira, Tania
    Teixeira, Rubina
    Sa, Anabela
    Soares, Paula
    [J]. REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY, 2012, 17 (06) : 376 - 383